RACK1 and cancer: Aberrant expression of RACK1 has been reported in numerous cancers [9–13]—particularly several squamous cell carcinomas such as esophageal squamous cell carcinoma (ESCC), oral squamous cell carcinoma (OSCC) and gastric cancer [14, 15, 18].